Consult the medical resource doctors trust
UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.
Related articles included with a subscription
Related Searches
| AuthorPatrick Niaudet, MD | Section EditorsTej K Mattoo, MD, DCH, FRCPHelen V Firth, DM, FRCP, DCH | Deputy EditorMelanie S Kim, MD |
As a subscriber you will have access to the full contents of this article
The nail-patella syndrome (NPS) or osteo-onychodysplasia is an autosomal dominant disorder characterized by hypoplastic or absent patella, dystrophic fingernails and toenails, and dysplasia of elbows and iliac horns [1,2]. Renal involvement is inconstant.
The estimated incidence of NPS is 22 per million [3,4]. The disease has been reported in patients all around the world.
The abnormal gene in NPS is located at the distal end of the long arm of chromosome 9. A transcription factor of the LIM-homeodomain type, which plays an important role for limb development in vertebrates, named LMX1B was mapped to the same location at 9q34. A large number of mutations in this gene have been identified in patients with NPS [5-7]; these defects are believed to result in the loss of function of this protein.
Based upon results in homozygous knock-out mice and in vitro assays, LMX1B binds to sequences near and helps control the transcription of multiple genes integral for proper glomerular basement membrane formation and/or glomerular podocyte differentiation and function [8-11]. These include the gene(s) for the following proteins:
| References |
Top
|
![]() |
Please wait |